Literature DB >> 23955261

Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells.

Ayumu Konno1, Anton N Shuvaev, Noriko Miyake, Koichi Miyake, Akira Iizuka, Serina Matsuura, Fathul Huda, Kazuhiro Nakamura, Shigeru Yanagi, Takashi Shimada, Hirokazu Hirai.   

Abstract

Spinocerebellar ataxia type 3 (SCA3) is caused by the abnormal expansion of CAG repeats within the ataxin-3 gene. Previously, we generated transgenic mice (SCA3 mice) that express a truncated form of ataxin-3 containing abnormally expanded CAG repeats specifically in cerebellar Purkinje cells (PCs). Here, we further characterize these SCA3 mice. Whole-cell patch-clamp analysis of PCs from advanced-stage SCA3 mice revealed a significant decrease in membrane capacitance due to poor dendritic arborization and the complete absence of metabotropic glutamate receptor subtype1 (mGluR1)-mediated retrograde suppression of synaptic transmission at parallel fiber terminals, with an overall preservation of AMPA receptor-mediated fast synaptic transmission. Because these cerebellar phenotypes are reminiscent of retinoic acid receptor-related orphan receptor α (RORα)-defective staggerer mice, we examined the levels of RORα in the SCA3 mouse cerebellum by immunohistochemistry and found a marked reduction of RORα in the nuclei of SCA3 mouse PCs. To confirm that the defects in SCA3 mice were caused by postnatal deposition of mutant ataxin-3 in PCs, not by genome disruption via transgene insertion, we tried to reduce the accumulation of mutant ataxin-3 in developing PCs by viral vector-mediated expression of CRAG, a molecule that facilitates the degradation of stress proteins. Concomitant with the removal of mutant ataxin-3, CRAG-expressing PCs had greater numbers of differentiated dendrites compared to non-transduced PCs and exhibited retrograde suppression of synaptic transmission following mGluR1 activation. These results suggest that postnatal nuclear accumulation of mutant ataxin-3 disrupts dendritic differentiation and mGluR-signaling in SCA3 mouse PCs, and this disruption may be caused by a defect in a RORα-driven transcription pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23955261     DOI: 10.1007/s12311-013-0516-5

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  30 in total

Review 1.  Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology.

Authors:  G Stevanin; A Dürr; A Brice
Journal:  Eur J Hum Genet       Date:  2000-01       Impact factor: 4.246

2.  Staggerer, a new mutation in the mouse affecting the cerebellum.

Authors:  R L SIDMAN; P W LANE; M M DICKIE
Journal:  Science       Date:  1962-08-24       Impact factor: 47.728

3.  Short- and long-term depression of rat cerebellar parallel fibre synaptic transmission mediated by synaptic crosstalk.

Authors:  Païkan Marcaggi; David Attwell
Journal:  J Physiol       Date:  2006-11-16       Impact factor: 5.182

Review 4.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

5.  Rescue of abnormal phenotypes in delta2 glutamate receptor-deficient mice by the extracellular N-terminal and intracellular C-terminal domains of the delta2 glutamate receptor.

Authors:  Takashi Torashima; Akira Iizuka; Hajime Horiuchi; Kazuhiro Mitsumura; Miwako Yamasaki; Chiho Koyama; Kiyohiko Takayama; Masae Iino; Masahiko Watanabe; Hirozaku Hirai
Journal:  Eur J Neurosci       Date:  2009-07-15       Impact factor: 3.386

Review 6.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

7.  A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography.

Authors:  K Tamayose; Y Hirai; T Shimada
Journal:  Hum Gene Ther       Date:  1996-03-01       Impact factor: 5.695

8.  Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia.

Authors:  Takashi Torashima; Chiho Koyama; Akira Iizuka; Kazuhiro Mitsumura; Kiyohiko Takayama; Shigeru Yanagi; Miho Oue; Haruyasu Yamaguchi; Hirokazu Hirai
Journal:  EMBO Rep       Date:  2008-03-14       Impact factor: 8.807

9.  Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter.

Authors:  Kiyohiko Takayama; Takashi Torashima; Hajime Horiuchi; Hirokazu Hirai
Journal:  Neurosci Lett       Date:  2008-07-25       Impact factor: 3.046

10.  Disruption of the nuclear hormone receptor RORalpha in staggerer mice.

Authors:  B A Hamilton; W N Frankel; A W Kerrebrock; T L Hawkins; W FitzHugh; K Kusumi; L B Russell; K L Mueller; V van Berkel; B W Birren; L Kruglyak; E S Lander
Journal:  Nature       Date:  1996-02-22       Impact factor: 49.962

View more
  29 in total

1.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

2.  Protective roles of MITOL against myocardial senescence and ischemic injury partly via Drp1 regulation.

Authors:  Takeshi Tokuyama; Hideki Uosaki; Ayumu Sugiura; Gen Nishitai; Keisuke Takeda; Shun Nagashima; Isshin Shiiba; Naoki Ito; Taku Amo; Satoshi Mohri; Akiyuki Nishimura; Motohiro Nishida; Ayumu Konno; Hirokazu Hirai; Satoshi Ishido; Takahiro Yoshizawa; Takayuki Shindo; Shingo Takada; Shintaro Kinugawa; Ryoko Inatome; Shigeru Yanagi
Journal:  iScience       Date:  2022-06-11

Review 3.  Cellular and circuit mechanisms underlying spinocerebellar ataxias.

Authors:  Pratap Meera; Stefan M Pulst; Thomas S Otis
Journal:  J Physiol       Date:  2016-06-12       Impact factor: 5.182

4.  Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.

Authors:  Anton N Shuvaev; Nobutake Hosoi; Yamato Sato; Dai Yanagihara; Hirokazu Hirai
Journal:  J Physiol       Date:  2016-09-15       Impact factor: 5.182

Review 5.  Are Type 1 metabotropic glutamate receptors a viable therapeutic target for the treatment of cerebellar ataxia?

Authors:  Emmet M Power; Natalya A English; Ruth M Empson
Journal:  J Physiol       Date:  2016-02-24       Impact factor: 5.182

6.  Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5.

Authors:  Karen R Armbrust; Xinming Wang; Tyisha J Hathorn; Samuel W Cramer; Gang Chen; Tao Zu; Takashi Kangas; Anastasia N Zink; Gülin Öz; Timothy J Ebner; Laura P W Ranum
Journal:  J Neurosci       Date:  2014-07-23       Impact factor: 6.167

7.  Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease.

Authors:  Catarina Oliveira Miranda; Adriana Marcelo; Teresa Pereira Silva; João Barata; Ana Vasconcelos-Ferreira; Dina Pereira; Clévio Nóbrega; Sónia Duarte; Inês Barros; Joana Alves; José Sereno; Lorena Itatí Petrella; João Castelhano; Vitor Hugo Paiva; Paulo Rodrigues-Santos; Vera Alves; Isabel Nunes-Correia; Rui Jorge Nobre; Célia Gomes; Miguel Castelo-Branco; Luís Pereira de Almeida
Journal:  Mol Ther       Date:  2018-07-12       Impact factor: 11.454

8.  Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors.

Authors:  Yasunori Matsuzaki; Ayumu Konno; Ryo Mukai; Fumiaki Honda; Masafumi Hirato; Yuhei Yoshimoto; Hirokazu Hirai
Journal:  Mol Neurobiol       Date:  2016-02-16       Impact factor: 5.590

Review 9.  From mice to men: lessons from mutant ataxic mice.

Authors:  Jan Cendelin
Journal:  Cerebellum Ataxias       Date:  2014-06-16

10.  Genes and genetic testing in hereditary ataxias.

Authors:  Erin Sandford; Margit Burmeister
Journal:  Genes (Basel)       Date:  2014-07-22       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.